08/04/2014 - 9:10am

Cardinal Health on Monday reported fourth-quarter fiscal 2014 revenue of $23 billion, down 9.8%.

 

07/31/2014 - 1:25pm

Dr. Reddy's Labs announced financial results for the quarter ended June 30, which includes consolidated revenues of Rs.35.2 billion, representing year-on-year growth of 24%.

07/31/2014 - 12:05pm

The Food and Drug Administration on Friday will publish the fiscal year 2015 generic drug user fee rates as required under the Food Drug and Cosmetic Act as amended by the Generic Drug User Fee Amendments of 2012.

07/31/2014 - 10:56am

Teva Pharmaceuticals on Thursday announced results for second-quarter 2014, which included revenues of $5 billion, an increase of 2% compared with the same period last year.

07/31/2014 - 8:17am

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

07/30/2014 - 10:58am

Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.

07/29/2014 - 1:31pm

The use of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending.

07/29/2014 - 1:14pm

The Food and Drug Administration may have more generic drug applications than it does personnel to process them, according to a Wall Street Journal report published Tuesday.

07/28/2014 - 12:46pm

The Food and Drug Administration has accepted a license application by Sandoz, Novartis' generics company, for a potential generic biologic drug, the company announced Monday.